期刊
NATURE REVIEWS CANCER
卷 1, 期 2, 页码 118-129出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/35101072
关键词
-
类别
A quarter of a century after their advent, monoclonal antibodies have become the most rapidly expanding class of pharmaceuticals for treating a wide variety of human diseases, including cancer. Although antibodies have yet to achieve the ultimate goal of curing cancer, many innovative approaches stand poised to improve the efficacy of antibody-based therapies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据